WILSON KAREN J
SEC Form 4 insider trading activity
WILSON KAREN J has filed 3 SEC Form 4 filings (5 transaction rows) across 2 companies, including SER, LVTX, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jun 15, 2026.
On the most recent filing, WILSON KAREN J is listed as Director at Serina Therapeutics, Inc. Inside the rolling window, WILSON KAREN J reported 4 open-market purchases totaling $55K in SER and no open-market sales. The largest disclosed transaction in the window is a purchase of 10,000 SER shares on May 22, 2026, worth $19K.
Companies traded
Other insiders at SER
Insider Buying
$55K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has WILSON KAREN J made?
WILSON KAREN J has filed 3 SEC Form 4 filings (5 transaction rows) across 2 companies, including SER, LVTX since 2025.
Which companies does WILSON KAREN J trade?
WILSON KAREN J has filed SEC Form 4 disclosures for 2 companies, including SER, LVTX.
When was WILSON KAREN J's most recent SEC Form 4 filing?
WILSON KAREN J's most recent SEC Form 4 filing on Tracefour is dated Jun 15, 2026.
What is WILSON KAREN J's total buy and sell value in the current window?
Inside the rolling retention window, WILSON KAREN J bought $55K and sold $0 based on SEC Form 4 filings.
What was WILSON KAREN J's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 10,000 SER shares on 2026-05-22, worth $19K, per SEC Form 4 filings.